New York 2025 Session Status: Introduced

A265 — Relates to the availability of opioid reversal agents

Last action — In Senate Committee

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Assembly
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the Assembly. Introduced January 08, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

Bill Text

Action History

  1. REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS

  2. DELIVERED TO SENATE

  3. PASSED ASSEMBLY

  4. ORDERED TO THIRD READING CAL.9

  5. RETURNED TO ASSEMBLY

  6. DIED IN SENATE

  7. DELIVERED TO SENATE

  8. PASSED ASSEMBLY

  9. ORDERED TO THIRD READING RULES CAL.705

  10. RULES REPORT CAL.705

  11. REPORTED

  12. REPORTED REFERRED TO RULES

  13. REPORTED REFERRED TO WAYS AND MEANS

  14. PRINT NUMBER 265A

  15. AMEND AND RECOMMIT TO ALCOHOLISM AND DRUG ABUSE

  16. REFERRED TO ALCOHOLISM AND DRUG ABUSE

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 218 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (218)

218 members have not signed on to this bill.

Show all 218 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does A265 do?
Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.
Who sponsors A265?
A265 is sponsored by Phil Steck.
What is the current status of A265?
This bill has been introduced in the Assembly. Introduced January 08, 2025. It must pass committee before a floor vote.
Where can I track A265?
Track A265 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on A265

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of A265

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →